These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 8398845)

  • 1. Alpha interferon raises serum beta-2-microglobulin in patients treated for thrombocythaemia.
    Remes K; Tienhaara A; Pelliniemi TT
    Br J Haematol; 1993 Jun; 84(2):353-5. PubMed ID: 8398845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of alpha-interferon on serum beta-2-microglobulin.
    Remes K; Tienhaara A; Pelliniemi TT
    Leuk Lymphoma; 1996 Apr; 21(3-4):233-8. PubMed ID: 8726404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Maintenance therapy in the myeloproliferative disorders: the current options.
    Giles FJ
    Br J Haematol; 1991 Oct; 79 Suppl 1():92-5. PubMed ID: 1931719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. alpha Interferon treatment of essential thrombocythaemia and other myeloproliferative disorders with excessive thrombocytosis.
    Yataganas X; Meletis J; Plata E; Viniou N; Deligiannis F; Tsekoura C; Voscaridou E; Boussiotis V; Rombos J; Vayopoulos G
    Eur J Cancer; 1991; 27 Suppl 4():S69-71. PubMed ID: 1799484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of essential thrombocythaemia by alpha 2a interferon.
    Bellucci S; Harousseau JL; Brice P; Tobelem G
    Lancet; 1988 Oct; 2(8617):960-1. PubMed ID: 2902403
    [No Abstract]   [Full Text] [Related]  

  • 6. alpha Interferon in the management of essential thrombocythaemia.
    Giralt M; Rubio D; Cortés MT; San Miguel J; Steegmann JL; Serena J; Fernández-Rañada JM; López-Borrasca A
    Eur J Cancer; 1991; 27 Suppl 4():S72-4. PubMed ID: 1799486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interferon alpha-2b in the long-term treatment of essential thrombocythemia.
    Sacchi S; Tabilio A; Leoni P; Riccardi A; Vecchi A; Messora C; Falzetti F; Rupoli S; Ucci G; Martelli MF
    Ann Hematol; 1991 Oct; 63(4):206-9. PubMed ID: 1932299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment with recombinant interferon-alpha-2C: multiple myeloma and thrombocythaemia in myeloproliferative diseases.
    Ludwig H; Cortelezzi A; Van Camp BG; Polli E; Scheithauer W; Kuzmits R; Linkesch W; Gisslinger H; Sinzinger H; Fritz E
    Oncology; 1985; 42 Suppl 1():19-25. PubMed ID: 4080297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of thrombocytosis in myeloproliferative disorders with interferon alpha-2a.
    Tichelli A; Gratwohl A; Berger C; Lori A; Würsch A; Dieterle A; Thomssen C; Nissen C; Holdener E; Speck B
    Blut; 1989 Jan; 58(1):15-9. PubMed ID: 2644994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum beta-2-microglobulin in patients with multiple myeloma treated with alpha interferon.
    Murakami H; Ogawara H; Morita K; Saitoh T; Matsushima T; Tamura J; Sawamura M; Karasawa M; Miyawaki S; Schimano S; Satoh S; Tsuchiya J
    J Med; 1997; 28(5-6):311-8. PubMed ID: 9604789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Interferon therapy in essential thrombocythemia].
    Seewann HL
    Wien Med Wochenschr; 1993; 143(16-17):420-4. PubMed ID: 8273365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sustained complete hematological remission in essential thrombocythemia after discontinuation of long-term alpha-IFN treatment.
    Sacchi S; Tabilio A; Leoni P; Riccardi A; Vecchi A; Messora C; Bensi L; Falzetti F; Rupoli S; Ucci G
    Ann Hematol; 1993 May; 66(5):245-6. PubMed ID: 8507719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of essential thrombocythaemia with interferon alpha-2b.
    May D; Wandl UB; Niederle N
    Lancet; 1989 Jan; 1(8629):96. PubMed ID: 2562897
    [No Abstract]   [Full Text] [Related]  

  • 14. Interferon alpha-2b as treatment for Philadelphia-negative chronic myeloproliferative disorders with excessive thrombocytosis.
    Lazzarino M; Vitale A; Morra E; Gagliardi A; Bernasconi P; Torromeo C; Inverardi D; Burgio V; Castello A; Bernasconi C
    Br J Haematol; 1989 Jun; 72(2):173-7. PubMed ID: 2757963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet counts during pregnancy in essential thrombocythaemia treated with recombinant alpha-interferon.
    Pulik M; Lionnet F; Genet P; Petitdidier C; Jary L
    Br J Haematol; 1996 May; 93(2):495. PubMed ID: 8639457
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment of thrombocytosis in chronic myeloproliferative disorders with interferon alfa-2b.
    Seewann HL; Zikulnig R; Gallhofer G; Schmid C
    Eur J Cancer; 1991; 27 Suppl 4():S58-62; discussion S62-3. PubMed ID: 1799482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes of serum neopterin, beta 2-microglobulin and interferon-gamma in patients with chronic hepatitis C treated with interferon-alpha 2b.
    Fuchs D; Norkrans G; Wejstal R; Reibnegger G; Weiss G; Weiland O; Schvarcz R; Fryden A; Wachter H
    Eur J Med; 1992; 1(4):196-200. PubMed ID: 1341444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effectiveness of interferon alfa in different stages of thrombocythemia (preliminary report)].
    Majcher A; Deptała A; Konopka L; Pawelski S
    Acta Haematol Pol; 1991; 22(1):82-91. PubMed ID: 1823971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [alpha-Interferon in the treatment of essential thrombocythemia].
    Hashizume M; Iki S; Yagisawa M; Ohbayashi Y; Sato H; Urabe A
    Rinsho Ketsueki; 1992 Feb; 33(2):232-7. PubMed ID: 1635175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transient normal platelet counts and decreased requirement for interferon during pregnancy in essential thrombocythaemia.
    Shpilberg O; Shimon I; Sofer O; Dolitski M; Ben-Bassat I
    Br J Haematol; 1996 Feb; 92(2):491-3. PubMed ID: 8603023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.